| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.076 | 0.06 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.079 | 0.08 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.041 | 0.4 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.037 | 0.4 |